| AASLD

Letter to the Editor: Echocardiographic Predictors of a Worse Outcome in Patients With Liver Cirrhosis: What Should We Assess?

Read more about Letter to the Editor: Echocardiographic Predictors of a Worse Outcome in Patients With Liver Cirrhosis: What Should We Assess?

Roxana Cristina Rimbaş, Mihai Rimbaş, Dragoș Vinereanu – 25 February 2019

Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus–Associated Hepatocellular Carcinoma

Read more about Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus–Associated Hepatocellular Carcinoma

Yung‐Tsung Li, Hui‐Lin Wu, Jia‐Horng Kao, Huei‐Ru Cheng, Ming‐Chih Ho, Chih‐Chiang Wang, Pei‐Jer Chen, Ding‐Shinn Chen, Chun‐Jen Liu – 25 February 2019 – Overexpression of metastatic tumor antigen 1 (MTA1) was correlated with poor prognosis of hepatitis B virus (HBV)‐associated hepatocellular carcinoma (HBV‐HCC). The aim of this study was to examine the clinical significance of the expression of MTA1 and its exon 4‐excluded form (MTA1dE4), the most abundant spliced variant of MTA1, in patients receiving curative resection for HBV‐HCC.

Letter to the Editor: Defining Acute on Chronic Liver Failure: More Elusive Than Ever

Read more about Letter to the Editor: Defining Acute on Chronic Liver Failure: More Elusive Than Ever

Jasmohan S. Bajaj, Florence Wong, Patrick S. Kamath – 25 February 2019

Letter to the Editor: Tuberculosis and Antituberculosis Treatments Cannot Be Ignored When Evaluating Patients With Cirrhosis Who Are Coinfected With HIV or Not

Read more about Letter to the Editor: Tuberculosis and Antituberculosis Treatments Cannot Be Ignored When Evaluating Patients With Cirrhosis Who Are Coinfected With HIV or Not

RuiLing Wang, Peng Zhu – 25 February 2019

Letter to the Editor: Deliberations More Than a Cut‐off Hepatitis B Surface Antigen Value for Nucleos(t)ide Analogue Cessation

Read more about Letter to the Editor: Deliberations More Than a Cut‐off Hepatitis B Surface Antigen Value for Nucleos(t)ide Analogue Cessation

Wen‐Juei Jeng, Yao‐Chun Hsu, Tung‐Hung Su, Chien‐Hung Chen – 22 February 2019

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Read more about Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Jorge A. Marrero, Laura M. Kulik, Claude B. Sirlin, Andrew X. Zhu, Richard S. Finn, Michael M. Abecassis, Lewis R. Roberts, Julie K. Heimbach – 21 February 2019

The Antiresection Activity of the X Protein Encoded by Hepatitis Virus B

Read more about The Antiresection Activity of the X Protein Encoded by Hepatitis Virus B

Laifeng Ren, Ming Zeng, Zizhi Tang, Mingyuan Li, Xiaojun Wang, Yang Xu, Yuding Weng, Xiaobo Wang, Huan Wang, Liandi Guo, Bing Zuo, Xin Wang, Si Wang, Jiangyan Lou, Yaxiong Tang, Dezhi Mu, Ning Zheng, Xianhui Wu, Junhong Han, Antony M. Carr, Penelope Jeggo, Cong Liu – 21 February 2019 – Chronic infection of hepatitis B virus (HBV) is associated with an increased incidence of hepatocellular carcinoma (HCC).

Phenobarbital‐Induced Liver Injury With Nodal Angiomatosis

Read more about Phenobarbital‐Induced Liver Injury With Nodal Angiomatosis

Li‐Ting Cheng, Matthew M. Yeh, Chun‐Chi Lu – 21 February 2019

Treatment for Advanced Hepatocellular Carcinoma: Current Standard and the Future

Read more about Treatment for Advanced Hepatocellular Carcinoma: Current Standard and the Future